Selected article for: "dna sample and single sample"

Author: Sofia Morfopoulou; Vincent Plagnol
Title: Bayesian mixture analysis for metagenomic community profiling.
  • Document date: 2014_7_25
  • ID: 058r9486_1
    Snippet: Metagenomics can be defined as the analysis of a collection of DNA or RNA sequences originating from a single sample. In practice, its scope is broad and includes the analysis of a diverse set of samples such as gut microbiome (Qin et al., 2010) , (Minot et al., 2011) , environmental (Mizuno et al., 2013) or clinical (Willner et al., 2009) , (Negredo et al., 2011 ), (McMullan et al., 2012 samples. Among these applications, the discovery of viral .....
    Document: Metagenomics can be defined as the analysis of a collection of DNA or RNA sequences originating from a single sample. In practice, its scope is broad and includes the analysis of a diverse set of samples such as gut microbiome (Qin et al., 2010) , (Minot et al., 2011) , environmental (Mizuno et al., 2013) or clinical (Willner et al., 2009) , (Negredo et al., 2011 ), (McMullan et al., 2012 samples. Among these applications, the discovery of viral pathogens is clearly relevant for clinical practice (Fancello et al., 2012) , (Chiu, 2013) . The traditional process of characterizing a virus through potentially difficult and time consuming culture techniques is being revolutionized by advances in high throughput sequencing. Potential benefits of sequence driven methodologies include a more rapid turnaround time (Quail et al., 2012) , combined with a largely unbiased approach in species detection, including the opportunity for unexpected discoveries.

    Search related documents:
    Co phrase search for related documents
    • clinical practice and high throughput sequencing: 1, 2, 3, 4, 5, 6
    • clinical practice and potential benefit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • clinical practice and RNA dna: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • clinical practice and single sample: 1, 2
    • clinical practice and throughput sequencing: 1, 2, 3, 4, 5, 6
    • clinical practice and traditional process: 1, 2
    • clinical practice and turnaround time: 1, 2, 3, 4, 5, 6, 7, 8
    • clinical practice and viral pathogen: 1, 2, 3, 4
    • culture technique and high throughput sequencing: 1
    • culture technique and throughput sequencing: 1
    • diverse set and high throughput sequencing: 1
    • diverse set and RNA dna: 1, 2, 3, 4, 5
    • diverse set and throughput sequencing: 1
    • diverse set and turnaround time: 1
    • diverse set and viral pathogen: 1
    • high throughput sequencing and potential benefit: 1
    • high throughput sequencing and RNA dna: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high throughput sequencing and single sample: 1, 2, 3, 4
    • high throughput sequencing and species detection: 1